With the recent approval of anti-immunoglobulin E (IgE) therapy for FA, pediatricians and allergists will benefit from this lively conversation between 2 experts on the current state of FA management, trial data related to anti-IgE therapy, and considerations for treatment of FA.
- Provider:Paradigm Medical Communications, LLC
- Activity Link: https://ce.paradigmmc.com/a/XHLENA
- Start Date: 2024-05-31 05:00:00
- End Date: 2024-05-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Genentech (Any division) - Amount: 154575.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest